Parp Inhibitors: Treatment and Adverse Events with Ainhoa Madariaga - a podcast by BMJ Group

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ainhoa Madariaga to discuss parp inhibitor treatments and adverse events. Dr. Madariaga's article, "Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events," (https://ijgc.bmj.com/content/early/2020/06/08/ijgc-2020-001288) is the Lead Article in the July 2020 issue of IJGC. Dr. Madariaga is a medical oncologist working as a clinical research fellow in the gynecology and drug development program at Princess Margaret Cancer Centre. Her clinical and academic areas of interest are gynecologic cancers and early phase clinical trial design; such as development of drug-repurposing studies, cancer treatment adverse event and patient reported outcomes assessment.

Further episodes of IJGC Podcast

Further podcasts by BMJ Group

Website of BMJ Group